Michael Park, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 430 W Centre Ave, Portage, MI 49024 Phone: 269-321-6673 Fax: 269-324-5594 |
News Archive
Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc. U.S., submitted a New Drug Application to the U.S. Food and Drug Administration for an investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone for the treatment of hypertension, or high blood pressure.
The U.S. Centers for Disease Control and Prevention (CDC) recently published a new guideline, recognizing that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can spread via aerosols. Now, the health agency takes back its statement by deleting the updates published on Sept. 18.
Authorities in the United States have given approval for the first drug to treat the condition fibromyalgia.
Biomax Informatics today announced the expansion of its long-term licensing and services agreement with Royal DSM to include solutions for synthetic biology using Biomax's BioXM Knowledge Management Environment.
Scientists have sequenced the complete genome of the naked mole rat, a pivotal step to understanding the animal's extraordinarily long life and good health. A colony of more than 2,000 naked mole rats at The University of Texas Health Science Center at San Antonio contributed to the findings, published today in the journal Nature.
› Verified 1 days ago